10020853 · Active · incorporated 10 years, 5 months ago · London
Healthtech Drug Discovery Healthcare Pre-Seed
The company is associated with the EPPIK clinical study, which is evaluating the safety and effectiveness of a drug called sparsentan for treating rare kidney diseases.
See the complete cap table with every shareholder, founder tags, dilution across 3 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.